EarningsQ4 2023 Earnings Report

United Therapeutics (UTHR) Q4 2023 Earnings Report

0 Followers

MX:UTHR Q4 2023 EPS Results

Actual EPS$78.50

Consensus EPS$75.39

Beat/MissBeat by +$3.11

One Year Ago EPS$48.07

Actual Revenue$11.07B

Expected Revenue$10.35B

Beat/MissBeat by +$714.66M

YoY Revenue Growth+25.07%

QuarterQ4 2023

Date02/21/2024

TimeBefore Open

Conference CallWednesday, February 21, 2024

MX:UTHR Upcoming Earnings

United Therapeutics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

MX:UTHR Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	115.28 / -	128.914	―
Aug 05, 2026	2026 (Q2)	123.55 / 130.89	115.41	13.42% (+15.48)
May 06, 2026	2026 (Q1)	126.00 / 104.79	119.371	-12.22% (-14.58)
Feb 25, 2026	2025 (Q4)	128.37 / 138.64	111.449	24.39% (+27.19)
Oct 29, 2025	2025 (Q3)	131.74 / 128.91	115.05	12.05% (+13.86)
Jul 30, 2025	2025 (Q2)	131.34 / 115.41	105.328	9.57% (+10.08)
Apr 30, 2025	2025 (Q1)	120.56 / 119.37	111.089	7.46% (+8.28)
Feb 26, 2025	2024 (Q4)	115.23 / 111.45	78.501	41.97% (+32.95)
Oct 30, 2024	2024 (Q3)	117.44 / 115.05	96.865	18.77% (+18.18)
Jul 31, 2024	2024 (Q2)	117.12 / 105.33	94.345	11.64% (+10.98)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed